- Abstract
- Core Tip
- Article Highlights
- Full Article with Cover (PDF)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (2194)
- Timeline of Article Publication (3)
- Authors Evaluation (2)
- Article Quality Tracking (1)
- Reader Comments (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9649)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2021 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Han Y, Zhi WH, Xu F, Zhang CB, Huang XQ, Luo JF. Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials. World J Gastroenterol 2021; 27(19): 2415-2433 [PMID: 34040331 DOI: 10.3748/wjg.v27.i19.2415] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i19/2415.htm |
| Number | Citing Articles |
| 1 |
Yi Liu, Juan Xiang, Gang Peng, Chenfu Shen. Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.785370
|
| 2 |
|
| 3 |
Bin Xu, Hui-Chuan Sun. Camrelizumab: an investigational agent for hepatocellular carcinoma. Expert Opinion on Investigational Drugs 2022; 31(4): 337 doi: 10.1080/13543784.2022.2022121
|
| 4 |
Federica Lo Prinzi, Federico Rossari, Marianna Silletta, Silvia Foti, Silvia Camera, Francesco Vitiello, Elisabeth Amadeo, Francesco De Cobelli, Luca Aldrighetti, Margherita Rimini, Andrea Casadei-Gardini. Intermediate hepatocellular carcinoma: new horizons and prospects for our patients. Expert Review of Gastroenterology & Hepatology 2024; 18(10): 661 doi: 10.1080/17474124.2024.2422367
|
| 5 |
Jinfeng Bai, Ming Huang, Bohan Song, Wei Luo, Rong Ding. The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma. Technology in Cancer Research & Treatment 2023; 22 doi: 10.1177/15330338231159718
|
| 6 |
Jingxin Yan, Manjun Deng, Ting Li, Changhao Dong, Minglan Wang, Shunyu Kong, Yingxing Guo, Haining Fan. Efficacy and complications of transarterial chemoembolization alone or in combination with different protocols for hepatocellular carcinoma: A Bayesian network meta-analysis of randomized controlled trials. iLIVER 2023; 2(2): 130 doi: 10.1016/j.iliver.2023.03.002
|
| 7 |
Leonardo Gomes da Fonseca, Raphael L C Araujo. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities. World Journal of Gastroenterology 2022; 28(28): 3573-3585 doi: 10.3748/wjg.v28.i28.3573
|
| 8 |
Ping Li, Ming Hu, Mei Liu, Xiangyu Ren, Donghong Liu, Jiluo Liu, Jianhua Yin, Xiaojie Tan, Guangwen Cao. The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1197782
|
| 9 |
Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, Lorenza Rimassa, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Tiziana Pressiani, Takumi Kawaguchi, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Fabio Piscaglia, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Mario Scartozzi, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Antonella Cammarota, Valentina Burgio, Stefano Cascinu, Andrea Casadei-Gardini. Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study. Journal of Cancer Research and Clinical Oncology 2023; 149(9): 5591 doi: 10.1007/s00432-022-04512-1
|
| 10 |
Zebing Song, Xiaodong Song, Hang Li, Zongbing Cheng, Zengyi Mo, Xuewei Yang. Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1236995
|
| 11 |
Ignacio Ventura, Lorena Sanchiz, María Ester Legidos-García, María Teresa Murillo-Llorente, Marcelino Pérez-Bermejo. Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer. Cancers 2023; 16(1): 197 doi: 10.3390/cancers16010197
|
| 12 |
Heng Dong, Zhengguo Zhang, Mengjie Ni, Xiaoyun Xu, Yifeng Luo, Yaru Wang, Haiyun Zhang, Jianxiang Chen. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy. Current Treatment Options in Oncology 2024; 25(10): 1239 doi: 10.1007/s11864-024-01246-9
|
| 13 |
Maria Cerreto, Ferdinando Cardone, Lucia Cerrito, Leonardo Stella, Francesco Santopaolo, Maria Pallozzi, Antonio Gasbarrini, Francesca Romana Ponziani. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence. Current Oncology 2023; 30(10): 8774 doi: 10.3390/curroncol30100633
|
| 14 |
Osama Altayar, Raj Shah, Charissa Y. Chang, Yngve Falck-Ytter, Andrew J. Muir. AGA Technical Review on Systemic Therapies for Hepatocellular Carcinoma. Gastroenterology 2022; 162(3): 937 doi: 10.1053/j.gastro.2021.12.275
|
| 15 |
Hui-Chuan Sun, Xiao-Dong Zhu. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.772195
|
| 16 |
Yunyan Ling, Meng Jin, Meiyan Zhu, Yan Wang, Yong Chen, Zhenwei Peng. Efficacy of Different Treatments for Patients with Advanced Hepatocellular Carcinoma: A System Review and Network Meta-Analysis. International Journal of Surgery Oncology 2022; 7(1): 58 doi: 10.29337/ijsonco.140
|